Document is current
Any future updates will be listed below
-
Authors
Yang, Shuiquan
Yao, Weiping
Siegler, James E.
Mofatteh, Mohammad
Wellington, Jack
Wu, Jiale
Liang, Wenjun
Chen, Gan
Huang, Zhou
Yang, Rongshen
Chen, Juanmei
Yang, Yajie
Hu, Zhaohui
Chen, Yimin
-
Funding
Funding for this research was provided by:
Foshan the 14th Five-Year Plan Key Discipline Foundation-Department of Neurology
Foshan Medical Technology Innovation Platform Construction Fundation (FS0AA-KJ218-1301-0012, FS0AA-KJ218-1301-0012)
- License Information
-
More Information
Article History
Received: 6 April 2022
Accepted: 15 July 2022
First Online: 26 July 2022
Declarations
:
: The study was approved by Foshan Sanshui District People’s Hospital Institute Review board. The informed consent was waived due to the retrospective observational nature of the study by Foshan Sanshui District People’s Hospital Institute Review Board. All the studies were carried out in the accordance with the relevant guidelines and regulations.
: Not applicable.
: James E. Siegler reports consulting fees for Ceribell and speakers bureau for AstraZeneca, both unrelated to the present work. Other authors have no conflict of interest.
